NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC-Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation) Meeting Abstract
| Authors: | Kong, F. M. S.; Hu, C.; Ten Haken, R.; Xiao, Y.; Matuszak, M.; Hirsh, V.; Pryma, D. A.; Siegel, B. A.; Gelblum, D. Y.; Hayman, J.; Robinson, C. G.; Loo, B. W.; Videtic, G. M. M.; Faria, S.; Ferguson, C.; Dunlap, N. E.; Kundapur, V.; Paulus, R.; Bradley, J. D.; Machtay, M. |
| Abstract Title: | NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC-Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604262 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.8548 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8548 -- Source: Wos |
